Why the study?
Data were needed to inform ethical and policy decisions regarding post-trial access to implantable neurotechnology, as in-depth examinations of researcher and patient-participant perspectives remained limited.
Provides data on researcher and patient perspectives to inform ethical and policy decisions about post-trial access to implantable neurotechnology.
Answers are grounded in this paper and cite their sources.
Informs ethical post-trial access policies for neurotechnology; leaves open standardized implementation across trials.
To our knowledge, this is the first in-depth examination of researcher perspectives regarding continued access to experimental neural devices and only the second such examination of patient-participant perspectives. These data can help inform future ethical and policy decisions about post-trial access to implantable neurotechnology.
No takes yet. Share an insight, caveat, or question.
Lázaro‐Muñoz et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: